Vitronectin XF??? 2 mL

The University of Virginia awarded contract A207_PO-0470446 to StemCell Technologies Inc on August 19, 2026, for the delivery of biological research materials. The prime contractor is obligated to supply one unit of Vitronectin XF, a specialized protein product commonly used in cell culture applications, with delivery directed to Lavie L Ngo. The total contract value is ninety-three dollars ($93), representing a purchase order for a single line item at a unit price of ninety-three dollars per unit.

This Virginia-based contract award reflects a routine procurement transaction for laboratory reagents necessary to support research operations at the University of Virginia. While the contract documentation does not specify a distinct performance period beyond the award date of August 19, 2026, the transactional nature of the purchase order indicates immediate fulfillment expectations. No cumulative or annual value information beyond the stated ninety-three dollar cumulative value has been provided in the contract documentation.